ABSTRACT
CONTEXT: Insulin autoimmune syndrome (IAS, Hiratadisease)isararecauseofhypoglycemia in Western countries. It is characterized by hypoglycemicepisodes,elevatedinsulinlevels, and positive insulin antibodies. Our objective is to report a case of IAS identified in South America.
CASE REPORT: A 56-year-old Caucasian male patient started presenting neuroglycopenic symptomsduringhospitalizationduetosevere trauma.Biochemicalevaluationconfirmedhypo-glycemiaandabnormallyhighlevelsofinsulin. Conventionalimagingexaminationswerenega-tiveforpancreatictumor.Insulinantibodieswere abovethenormalrange.Clinicalremissionofthe episodeswasnotachievedwithverapamiland steroids.Thus,asubtotalpancreatectomywas performedduetothelackofresponsetoconser- vativetreatmentandbecauseimmunosuppres-santswerecontraindicatedduetobacteremia. Histopathologicalexaminationrevealeddiffuse hypertrophyofbetacells.Thepatientcontinues tohavehighinsulinlevelsbutisalmostfreeof hypoglycemicepisodes.
KEY WORDS: Hypoglycemia. Hyperinsulinism. Insulin.Pancreatectomy.Insulinantibodies.
Insulinautoimmune
syndrome:casereport
EndocrinologyService,HospitalUniversitárioClementinoFragaFilho,
UniversidadeFederaldoRiodeJaneiro,RiodeJaneiro,Brazil
•RodrigoOliveiraMoreira
•GiovannaAparecidaBalariniLima
•PatríciaCarlaBatistaPeixoto
•MariaLuciaFleiussFarias
•MarioVaisman
C
aseR
epor
t
INTRODUCTION
Insulinautoimmunesyndrome(IAS,Hirata disease)isanunusualcauseofhypoglycemia.It ischaracterizedbyspontaneoushypoglycemia, extremelyhighinsulinlevels,andthepresence ofcirculatinginsulinantibodiesinpatientswho haveneverbeenexposedtoexogenousinsulin. Although IAS is considered to be the third greatestcauseofhypoglycemiainJapan,onlya handfulofcaseshavebeenreportedinWestern countries.1Ourobjectiveistoreportacaseof
IASidentifiedinSouthAmerica.
CaseReport
Mr. A, a 56-year-old retired Caucasian man,presentedepisodesofsymptomatichypo-glycemiaduringhospitalizationduetosevere trauma.Hewassubmittedtoamputationofthe rightleg,developedseveresepsis,andhadtobe keptonwide-spectrumantibiotics.Histreat-mentincludeddopamine,becauseoftheseptic shock,andcontinuousintravenousglucosefor thepreventionofhypoglycemia.Endogenous hyperinsulinemiawassuspected,andthiswas confirmedbythepatient’slowglycemiclevel, elevated serum insulin (23710 µIU/ml, after 1/50dilutionoftheserum),andhighserum levels of C peptide (4.2 ng/ml). He said he hadnotbeenusingexogenousinsulinandwas unawareofcasesofhypoglycemiainhisfamily. At that moment, conventional imaging examinationswererequestedinanattemptto investigatethepossibilityofinsulinoma.Ab-dominalultrasound,computedtomographyand pancreaticarteriographywerenegative.However, selectivearterialcalciumstimulationandhepatic
venoussampling(ASVS)demonstratedhighlevels ofinsulinandCpeptideinthewholepancreasand noresponsetocalciumstimulation(Table1).
Duringthepreoperativeperiod,verapamil andprednisonewereprescribedwithoutsuc-cess. After five months in hospital, no signs of remission of hypoglycemia were detected. Surgerywasindicatedduetotheseverityofthe episodesandbecauseimmunosuppressantswere contraindicatedduetobacteremia.Duringthe operation,notumorwasfoundbypalpation, thuspromptingthedecisiontoperformsubtotal pancreatectomy.Histologicalexaminationdem-onstrateddiffusehyperplasiaofbetacells.
Data on antibody levels were available onlyafterthesurgicalprocedure.Thelevels ofisletcellantibody(ICA)andglutamicacid decarboxylase antibody (anti-GAD) were within normal range. Insulin auto-antibod-ies (IAA) were elevated (107.30 IU/ml; the referencerangeisfrom0.00to1.00).Insulin autoimmunesyndromewasthusidentifiedas thecauseofthehypoglycemia.
Thepatienthascontinuedtohavehypo-glycemicepisodes,albeitlessfrequentandless severe.Hisinsulin(2479µIU/ml)andCpep-tide(4.9ng/ml)serumlevelshavecontinuedto behigh,althoughlowerthantheinitiallevels. Because of his poor general health, we have decidednottosubmithimtoanynewinvasive procedure.Thepatientismaintainedonahy-percaloricdietandwithoutmedication.
DISCUSSION
ThemajorityofIAScasesarereportedin Japanesesubjects.1,2IASseemstoberelatedto
specificHLAclassIIalleles,whichare10to30
SãoPauloMedicalJournal—RevistaPaulistadeMedicina
179
timesmoreprevalentinJapaneseandKoreans than in Caucasians.2 Nevertheless, IAS has
alsobeenreportedinnon-Japanesesubjects. Up to 1999, ten cases had been identified in non-Japanese East Asians and only two inHispanicsubjects.1Recently,afewother
caseshavebeenreportedinEurope,including twoPortuguesesubjects.3Tothebestofour
knowledge,thisisprobablythefirstcaseof IASinaBrazilianpatient.
IASisusuallyrelatedtopreviousexposure todrugs.InaJapanesecaseseries,almost70% ofthepatientsreportedpreviousexposureto methimazole (49%),α-mercaptopropionyl glycine (43%), or glutathione (8%).Thus, drug-inducedinsulinantibodiesarethought to be associated with drugs containing the sulfhydrylgroup.Moreover,Graves’diseasein particularseemstobeariskfactorforinsulin autoimmunity.1 Although it is not possible
todeterminewhethertheuseofantibiotics duringhospitalizationtriggeredtheautoim- munityinourcase,wefeelthatthisisprob-ably the most plausible hypothesis. Indeed, antibioticshavealreadybeenassociatedwith thedevelopmentofIAS.3
InsulinlevelsinIASareusuallyextremely high.Theseresults,however,areaconsequence oftheinsulinantibodies,whichinterferewith
the insulin radioimmunoassay (RIA). If a doubleantibodytechniqueisemployed(us-ingRIA),theinsulinantibodieswillincrease immunoreactive insulin by competing with anti-insulinantibodies.2Ontheotherhand,
an immunoradiometric assay (IRMA) may havelowerfalse-positiveratesand,therefore, bemorereliable.2Hypoglycemiaissupposed
to be caused by the binding and release of theinsulinfromtheantibodies,whichoccur outofsynchronywiththeprevailingglucose concentration.2
Surgery is not currently indicated for thetreatmentofIAS.Morethan80%ofthe patients present remission within less than threemonthsafterdrugwithdrawal.Steroids, plasmapheresis,andimmunosuppressantscan also be used in some patients.The current recommendationsaretogivesixormoresmall mealsandtoavoidsweetsexceptatthetime ofhypoglycemicattack.1,2Ourpatientdidnot
presentclinicalremissionofthediseaseafter approximatelyfivemonthsofsymptoms.Also, steroidsandverapamilweretriedwithoutsuc-cess.Finally,thepresenceofsepsisthatwas resistanttoseveralantibioticscontraindicated the use of high dose immunosuppressants. Hence,theclinicalandsurgicalstaffdecided to submit him to subtotal pancreatectomy.
Fortunately,thesurgerywassuccessfulandthe patientisfreeofhypoglycemicepisodes.
Theeffectsofinsulinautoimmunityon thepancreasareonlypoorlyknown.Surgery hasonlybeenperformedonsevenpatients. Inthreecases,histopathologicalexamination identifiedhyperplasiaofbetacells.1Onecan
onlyspeculatethatthepresenceofthedisease overalongperiodmighthaveinducedbetacell proliferation(alsosuggestedbytheincreased Cpeptidelevels).Therefore,clinicaltreatment mightnotbeasefficientasinpatientswith rapidremissionofthedisease.
Insulinoma is the most prevalent cause ofhyperinsulinemichypoglycemia.1,4
There-fore,primaryinvestigationofhypoglycemia is always focused on its localization.When notumorislocatedbyanymeansavailable, thereisalwaysaquestiontoberaised:isthere atumoranywhereelseoristhereanyother causeforthehypoglycemia?Insulinantibody measurementmustbeperformedonallhy- poglycemicpatients.Althoughquiteuncom-mon,IASisacauseofhypoglycemiathatcan becuredwithoutsurgeryinthemajorityof thecases.Therefore,carefulinvestigationof the autoimmune mechanisms may prevent an unnecessary surgical procedure on a hy-poglycemicpatient.
Table1.InsulinandCpeptidelevelsduringarterialstimulationandvenoussampling(ASVS)inanadultpatientwithinsulinautoimmune syndrome(insulinresultswereonlyavailableafter1/50dilutionoftheserum)
Basal 30seconds 60seconds 120seconds
Arteries Insulin Cpeptide Insulin Cpeptide Insulin Cpeptide Insulin Cpeptide
Hepatic 5795 4.3 7605 4.3 6395 4.5 7185 4.0
Distalsplenic 3955 3.2 4005 3.6 4590 3.9 4895 3.7
Proximalsplenic 5330 3.8 5170 3.6 5520 3.5 5050 3.9
Gastroduodenal 7035 4.3 5785 4.2 7865 4.2 6365 4.2
Superiormesenteric 7740 4.4 5555 4.3 6245 4.5 6090 4.4
Referencevalues:insulin:5–25µIU/ml;Cpeptide:0.8–4.0ng/ml.
1. Uchigata Y, Hirata Y. Insulin autoimmune syndrome (IAS, Hirata disease). Ann Med Interne. 1999;150(3): 245-53.
2. Redmon JB, Nuttall FQ. Autoimmune hypoglycemia.
EndocrinolMetabClinNorthAm.1999;28(3):603-18. 3. Cavaco B, Uchigata Y, Porto T, Amparo-Santos M,
SobrinhoL,LeiteV.Hypoglycaemiaduetoinsulinautoim-munesyndrome:reportoftwocaseswithcharacterisation
of HLA alleles and insulin autoantibodies. Eur J Endocrinol.2001;145(3):311-6.
4. ThompsonGB.Diagnosisandmanagementofinsulinomas. EndocrPractice.2002;8:385-6.
REFERENCES
SãoPauloMedicalJournal—RevistaPaulistadeMedicina
180
Síndrome da Hiperinsulinemia Autoimune: relatodecaso
CONTEXTO:Asíndromedahiperinsulinemia autoimune(SHA,doençadeHirata)éuma causa rara de hipoglicemia nos países oci-dentais.Elaécaracterizadaporepisódiosde hipoglicemia, níveis elevados de insulina e presençadeanticorposanti-insulina.Nosso objetivoérelatarumcasodaSIAidentificado naAméricadoSul.
RELATODOCASO:Umhomemcaucasianode 56anosdeidadecomeçouaapresentarsinto-masneuroglicopênicosdurantehospitalização devidaatraumagrave.Aavaliaçãolaboratorial confirmouhipoglicemiaeníveisextremamente
elevadosdeinsulina.Osexamesradiológicos convencionaisrealizadosforamnegativospara tumorpancreático.Aremissãoclínicadadoença nãoocorreuduranteousodeverapamilecor-ticóides.Destaforma,pancreatectomiasubtotal foirealizadadevidoàausênciaderespostaao tratamentoconservadoreàimpossibilidadede serem utilizados imunosupressores em razão dabacteremiapersistente.Oexamehistopa-tológicorevelouhiperplasiadifusadecélulas beta.Opacientepersisteapresentandoníveis elevadosdeinsulinaporémpraticamentenão apresentamaisepisódiosdehipoglicemia.
PALAVRAS-CHAVE: Hipoglicemia.Hiperinsu- linismo.Insulina.Pancreatectomia.Anticor-posantiinsulina.
PUBLISHINGINFORMATION
Acknowledgements: Dr. Leonardo F Fontenelle for his criticalreviewofthemanuscript.
Rodrigo Oliveira Moreira, MD, MSc.Endocrinology Service, Hospital Universitário Clementino Fraga Filho, UniversidadeFederaldoRiodeJaneiro,RiodeJaneiro, Brazil.
GiovannaAparecidaBalariniLima,MD. Endocrinol-ogy Service, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro,Brazil.
Patrícia Carla Batista Peixoto, MD. Endocrinology Service, Hospital Universitário Clementino Fraga Filho, UniversidadeFederaldoRiodeJaneiro,Brazil.
MariaLuciaFleiussFarias,MD,PhD.Endocrinology Service, Hospital Universitário Clementino Fraga Filho, UniversidadeFederaldoRiodeJaneiro,RiodeJaneiro, Brazil.
MarioVaisman,MD,PhD. EndocrinologyService,Hos-pitalUniversitárioClementinoFragaFilho,Universidade FederaldoRiodeJaneiro,RiodeJaneiro,Brazil.
Sourcesoffunding:None
ConflictofInterest:None
Dateoffirstsubmission:August20,2003
Lastreceived:February6,2004
Accepted:March2,2004
Addressforcorrespondence:
RodrigoOliveiraMoreira
R.MiguelJoséMansur,300—Apto.401 JuizdeFora(MG)—Brasil—CEP36033-250 Tel.(+5521)2507-0065
Fax.(+5521)2224-9562 E-mail:rom_br@yahoo.com
COPYRIGHT©2004,AssociaçãoPaulistadeMedicina
RESUMO